ABSTRACT Leukocytic pyrogen is a small endogenous protein that mediates fever. Because of the limitations of ioassays, circulating leukocytic pyrogen has not been demonstrated during fever in humans. The pyrogen was produced in vitro after phagocytosis of staphylococci by blood monocytes. Antibody against the pyrogen was obtained from rabbits immunized with leukocytic pyrogen and the antiserum was purified by solid-phase immunoadsorbants. Purified antibody to the pyrogen was attached to activated Sepharose 4B and used in conjunction with gel filtration to purify the pyrogen. The pyrogen was labeled with 125I and further purified by gel filtration and ion-exchange chromatography. The final preparation of 125I-labeled pyrogen demonstrated a homogeneous band during isoelectric focusing and other separation procedures. With antibody to pyrogen attached to Sepharose, less than 0.1 of a rabbit pyrogenic dose of human leulocytic pyrogen inhibited the binding of 12'I4abeled pyrogen to this immunoadsorbant, and this inhibition was not affected by the presence of human serum. Thus, a radioimmunoassay for human leukocytic pyrogvn has been developed that may be used to detect circulating pyrogen during fever in humans. Fever is a major host response to many infectious, immunologic, and toxic agents. Although these agents have varied molecular compositions, it is hypothesized that they cause fever by inducing phagocytic leukocytes to synthesize and release a small mediator protein called leukocytic pyrogen (LP) (1). Subsequently, LP raises body temperature by its actions on specialized neurons in the pre-optic region of the anterior hypothalamus. In humans, LP is produced in vitro from stimulated phagocytes (2, 3), but circulating LP has yet to be convincingly demonstrated during febrile diseases (4). This may be due to the limitations of the bioassay for human LP, which utilizes the production of fever in rabbits. An immunoassay for human LP should be more sensitive than a bioassay. However, the lability and losses of LP during purification, as well as the lack of a specific antiserum, have hampered the development of an immunoassay. In a recent report (5), we described the production of specific rabbit antibody to human LP. Using this antiserum, we have developed a radioimmunoassay for human LP, which is the subject of this report.
MATERIALS AND METHODS
Human LP was produced in vitro after phagocytosis by peripheral blood monocytes of heat-killed staphylococci. The monocytes were obtained from Ficoll-Hypaque gradients of whole blood from normal volunteers (6) . Monocyte supernates containing LP were concentrated and the specific activity (protein per rabbit pyrogenic dose) was determined by a twopoint dose response curve in six rabbits as described previously (7, 8) . A peak rise in rectal temperature of 0.6-0.9°is considered a rabbit pyrogenic dose. Antiserum was obtained from rabbits after multiple injections of crude LP in Freund's adjuvant (5) . Immunoadsorbants were made with CNBr-activated Sepharose 4B (Pharmacia Fine Chemicals, Inc.) (9) . All gel-filtration media were autoclaved for 30 min and run in phosphatebuffered saline, pH 7.4, with 0.02% Na azide. Samples were placed on 0.1% sodium dodecyl sulfate (NaDodSO4)/7.5% polyacrylamide gels (125 X 5 mm) and were electrophoresed in 0.2 M Tris-borate buffer, pH 8.6 . Samples were first incubated at 600 for 1 hr in 1% NaDodSO4/10 mM Tris-borate/2 M urea. Gels were stained in 0.2% Coomassie blue and destained in a diffusion destainer (Bio-Rad Laboratories), and the absorbance of the bands was recorded on a scanning device at 525 nm (Helena Laboratories).
Isoelectric focusing was performed in 4.5% polyacrylamide in the presence of 1% Ampholines (LKB, pH 3-10). Gels were cooled at 40 for 18-20 hr and run at 250 V. Gels were cut and eluted in 0. Effect of Gel Filtration and Immunoadsorption on Purification of LP. Concentrated LP was chromatographed on Sephadex G-50 and the 15,000 molecular weight pyrogen peak was isolated and subjected to NaDodSO4/polyacrylamide gel electrophoresis. Fig. 1 (tracings A and B) compares the proteins present in crude LP with those isolated after gel filtration. This 15,000 molecular weight pyrogen peak was then applied to the anti-LP immunoadsorbant and the eluted pyrogen was subjected to electrophoresis. Fig. 1 (tracing C) reveals the presence of a homogeneous staining band.
With the combination of gel filtration and immunoadsorption, protein concentration of the pyrogen was low, and it was difficult to accurately calculate specific activity. Therefore, we labeled the 15,000 molecular weight pyrogen peak with 125I (Fig. 2) . The gels were sliced every 2 mm.
graphed over Sephadex G-50 was lyophilized and labeled with 0.5-1.0 mCi of 125I per 400 rabbit pyrogen doses. To remove unbound 1251, we used gel filtration. Fig. 2 depicts a typical experiment in which the labeled LP preparation was applied to a Sephadex G-15 column, and demonstrates three peaks of radioactivity. These peaks were pooled separately, and pyrogen activity was recovered only in pool I. NaDodSO4/polyacrylamide gel electrophoresis of pool I revealed a single localization of radioactivity occurring before the marker protein, cytochrome c. However, isoelectric focusing of pool I revealed three separate proteins (Fig. 3) . The pI values of these three proteins were 4.7, 5.6, and 7.0.
Ion Exchange of Labeled LP. It was clear that the homogeneous band of the pyrogen consisted of at least three proteins, as demonstrated by isoelectric focusing; thus, they should be separable during ion-exchange chromatography. Human LP elutes at low salt concentrations from DEAE-cellulose at pH 8.1 (7) . Fig. 4 demonstrates DEAE-cellulose ion-exchange (Fig. 4) obtained from ionexchange chromatography of 125I-labeled LP. Gels were sliced every 2.5 mm.
chromatography of pool I from the Sephadex G-15 gel filtration. The first major peak of radioactivity eluting at 3-5 mmho (pool I, Fig. 4) contained the pyrogen activity, as had been reported previously (7) . The recovery of biologically active pyrogen from the crude state to that following ion exchange was approximately 1%. LP isolated after ion exchange produced brief monophasic fevers in rabbits; heating this material at 800 for 15 min destroyed its pyrogenicity. When the pyrogen-containing peak from the DEAE-cellulose ion-exchange step was focused in polyacrylamide gels, a single major band of radioactivity was found at pH 7.0-7.1. (Fig. 5) . Further evidence that labeled LP was homogeneous was confirmed by chromatography on Sepharose CL-6B in 6 M guanidine.HCI, on hydroxylapatite in 0.1% NaDodSO4, and under a high pressure gradient of CH3CN/10 mM KH2PO4 using a Bondapak C18 column (Waters Associates). In each case, a single peak of radioactivity was observed. In addition, the 15,000-dalton LP trimerized into a 45,000-dalton molecule with a pI at 5.5. The existence and pyrogenicity of this larger molecular weight LP in crude leukocyte supernates has been previously demonstrated (6) . (Fig. 2) . The sample was dialyzed against 20 mM Tris, pH 8.1, before being applied to a 8 X 1.5-cm DEAE-cellulose (DE-52; Whatman, Ltd.) column equilibrated in the sample buffer and run at 40. NaCl was used as the salt gradient.
Proc. Natt. Acad. Sci. USA 7-4 (1977) Radioimiunoassay. Purified anti-human LP was attached to Sepharose 4B and suspended in phosphate-buffered saline with 0.1% casein (Hammersten). A source of human LP made from monocytes was assayed in rabbits, and increasing amounts of this LP preparation were added to the immunoadsorbant. After 24 hr at room temperature, 125I-labeled LP (stored in 0.1% casein) was added to each tube; after an additional 24 hr at room temperature, these were centrifuged at 1000 X g and washed once in H20. Radioactivity in the supernate, wash, and pellet was determined with a gamma counter, and the percent bound per total counts added was plotted against the pyrogenicity of LP in rabbits. Fig. 6 depicts a significant inhibition of the binding of 125I-labeled LP by less than 0.1 of a rabbit pyrogenic dose. The presence of normal human serum in these assays had no effect on the binding of labeled LP or on inhibition of binding by unlabeled LP in several experiments.
DISCUSSION
The association of fever and a circulating endogenous or leukocytic pyrogen has been well described in experimental animals (1) . There have been reports in which the rabbit or human bioassay has been adapted to study human LP during clinical fevers (4, 11); however, because of limitations of a bioassay, our knowledge of this molecule during fever has remained speculative. The development of a radioimmunoassay for human LP should provide answers to some perplexing problems concerning the pathogenesis of fever in humans.
In a previous study we reported the difficulties encountered in the purification of human LP obtained from peripheral neutrophils (7) . The purification of human LP in the present study was aided by the following: (i) the use of blood monocytes to produce LP in vitro since these cells release 20-40 times more LP per cell than neutrophils (6) ; (ii) the quantity of contaminating protein per rabbit pyrogenic dose is less in supernates from monocytes than from neutrophils; (iii) the use of a purified anti-LP immunoadsorbant, which provided us with greater recovery and purity of LP than previously described; and (iv) In this report the quantity of LP is expressed in rabbit pyrogenic doses. We are currently investigating the quantity of protein necessary to produce a rabbit pyrogenic dose. Nevertheless, the potential superiority of the radioimmunoassay over the bioassay is shown in this paper by the ability to detect less than 0.1 of a rabbit pyrogen dose in crude human Li. Thus, the radioimmunoassay should be able to replace the rabbit bioassay as a measure of human LP produced in the laboratory. Furthermore, since human serum did not interfere with the in vitro immunoassay, clinical studies now are possible.
